Literature DB >> 27050515

Uhrf1 Controls iNKT Cell Survival and Differentiation through the Akt-mTOR Axis.

Yu Cui1, Xufeng Chen1, Jiali Zhang1, Xiang Sun1, Haifeng Liu1, Li Bai2, Chenqi Xu1, Xiaolong Liu3.   

Abstract

Uhrf1 (also known as Np95) is a regulator of DNA methylation and histone ubiquitination and plays an important role in embryogenesis and tumorigenesis. Here, we report that Uhrf1 is essential for invariant natural killer T (iNKT) cell development. We found that Uhrf1 was significantly upregulated in stage 1 iNKT cells. Targeted disruption of Uhrf1 resulted in stage 1-specific transition defects as observed by not only increased apoptosis, but also aberrant effector differentiation, which eventually led to the impaired generation of iNKT cells in Uhrf1-deficient mice. Notably, Uhrf1 deficiency resulted in attenuated activation of Akt-mTOR signaling in stage 1 iNKT cells and overexpression of active Akt rescued iNKT cell developmental defects. Collectively, our results suggest that Uhrf1 regulation of the Akt-mTOR signaling pathway is required for iNKT cell development.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050515     DOI: 10.1016/j.celrep.2016.03.016

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

1.  Uhrf1 controls the self-renewal versus differentiation of hematopoietic stem cells by epigenetically regulating the cell-division modes.

Authors:  Jingyao Zhao; Xufeng Chen; Guangrong Song; Jiali Zhang; Haifeng Liu; Xiaolong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

2.  LiCl Treatment Induces Programmed Cell Death of Schwannoma Cells through AKT- and MTOR-Mediated Necroptosis.

Authors:  Ying Wang; Qi Zhang; Bo Wang; Peng Li; Pinan Liu
Journal:  Neurochem Res       Date:  2017-04-10       Impact factor: 3.996

3.  UHRF1 is required for basal stem cell proliferation in response to airway injury.

Authors:  Handan Xiang; Lifeng Yuan; Xia Gao; Peter B Alexander; Omar Lopez; Calvin Lau; Yi Ding; Mengyang Chong; Tao Sun; Rui Chen; Si-Qi Liu; Haiyang Wu; Ying Wan; Scott H Randell; Qi-Jing Li; Xiao-Fan Wang
Journal:  Cell Discov       Date:  2017-06-13       Impact factor: 10.849

4.  TGF-β signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity.

Authors:  Xiang Sun; Yu Cui; Haiyun Feng; Haifeng Liu; Xiaolong Liu
Journal:  J Exp Med       Date:  2019-09-12       Impact factor: 14.307

5.  A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State.

Authors:  Adeleye Opejin; Alexey Surnov; Ziva Misulovin; Michelle Pherson; Cindy Gross; Courtney A Iberg; Ian Fallahee; Jessica Bourque; Dale Dorsett; Daniel Hawiger
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

6.  Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity.

Authors:  Zheng-Jun Gao; Wen-Ping Li; Xin-Tao Mao; Tao Huang; Hao-Li Wang; Yi-Ning Li; Bao-Qin Liu; Jiang-Yan Zhong; Chai Renjie; Jin Jin; Yi-Yuan Li
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 14.307

7.  Uhrf1 regulates germinal center B cell expansion and affinity maturation to control viral infection.

Authors:  Chao Chen; Sulan Zhai; Le Zhang; Jingjing Chen; Xuehui Long; Jun Qin; Jianhua Li; Ran Huo; Xiaoming Wang
Journal:  J Exp Med       Date:  2018-04-04       Impact factor: 14.307

8.  UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.

Authors:  Limin Liu; Longyuan Hu; Linxuan Yang; Sujie Jia; Pei Du; Xiaoli Min; Jiali Wu; Haijing Wu; Hai Long; Qianjin Lu; Ming Zhao
Journal:  Clin Epigenetics       Date:  2021-02-10       Impact factor: 6.551

9.  Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Beina Hui; Shupei Pan; Shaomin Che; Yuchen Sun; Yanli Yan; Jia Guo; Tuotuo Gong; Juan Ren; Xiaozhi Zhang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.